Home > For Healthcare Professionals > Technical Resources

Technical Resources

Pharmacists CARE Initiative Resources

Resources to help you deliver medication abortion and early pregnancy loss care.

While some states are attempting to override the FDA through legislation that would impose medically unjustifiable barriers to care, the pharmacy community should know that medication abortion is FDA-approved, safe, effective, and can now be legally dispensed by certified retail and mail order pharmacies. On January 3rd, 2023, the FDA released updated Risk Evaluation and Mitigation Strategies (REMS) for Mifepristone, opening a pathway for pharmacies in all settings to become certified to dispense mifepristone.

To help you deliver medication abortion care, we have created and curated the following regulatory guidance, training materials, and clinical resources. Learn more about the Pharmacists CARE Initiative here.

PHARMACISTS SHOULD KNOW THAT...

Medication abortion care is FDA-approved, safe, and effective
Medication abortion has been in use for 20+ years
More than 4.9 million people have safely used medication abortion since its approval in 2000
Serious adverse events occur in fewer than 0.5% of medication abortions

As of 2023, medication abortions account for 63% of all US abortions
99.6% effective within the first 10 weeks of gestation
Mifepristone and misoprostol are also used to manage early pregnancy loss or miscarriage

PRESCRIBERS SHOULD KNOW THAT...

Mifepristone and misoprostol do not need to be dispensed at the healthcare provider’s office. These prescriptions can now be filled at certified pharmacies, following a change in the mifepristone REMS in 2023. This allows you to provide care in person or via telehealth and prescribe the medications, without having to stock and manage dispensing.